BioXcel Therapeutics, Inc. Soared
Tue, Dec 31, 2019 at 05:30 PM
BioXcel Therapeutics, Inc. (BTAI:NASDAQ) jumped higher at $14.61, a gain of 40.3%. On Mon 30 Dec 19, BTAI:NASDAQ touched a New 2-Week High of $10.41. The stock appeared on our News Catalysts scanner on Mon 30 Dec 19 at 08:39 AM in the 'BIOTECH' category. From Mon 09 Dec 19, the stock recorded 64.29% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About BioXcel Therapeutics, Inc. (BTAI:NASDAQ)
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
Top 10 Gainers:
- Spirit Realty Capital, Inc. (SRC:NYSE), 66.67%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 49.4%
- Viveve Medical, Inc. (VIVE:NASDAQ), 46.51%
- Inpixon (INPX:NASDAQ), 43.61%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 40.35%
- Neovasc Inc. (NVCN:NASDAQ), 36.96%
- Mereo BioPharma Group plc (MREO:NASDAQ), 32.26%
- Lincoln Educational Services Corporation (LINC:NASDAQ), 25%
- Jaguar Health, Inc. (JAGX:NASDAQ), 23.02%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 23%